NCT02858791 MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT02847260 Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) Status COMPLETED Phase PHASE4
NCT02845518 Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA) Status RECRUITING Phase NA
NCT02800941 Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension Status COMPLETED Phase N/A
NCT02799771 HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION Status COMPLETED Phase N/A
NCT02782052 Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension Status WITHDRAWN Phase PHASE3
NCT02763735 Right Ventricular Metabolism in Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT02746237 Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585 Status COMPLETED Phase PHASE1
NCT02736149 Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) Status TERMINATED Phase PHASE2
NCT02734953 Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH Status COMPLETED Phase PHASE2
NCT02725372 Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH Status TERMINATED Phase PHASE3
NCT02691689 Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions Status RECRUITING Phase NA
NCT02676947 A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT02664558 A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) Status COMPLETED Phase PHASE2
NCT02652429 Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH Status UNKNOWN Phase PHASE3
NCT02631421 Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH Status COMPLETED Phase N/A
NCT02583906 Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment Status TERMINATED Phase NA
NCT02579954 Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension Status COMPLETED Phase NA